Transdermal anesthetic and vasodilator composition and methods for topical administration
First Claim
Patent Images
1. A local, topical transdermal anesthetic and vasodilator formulation comprising a therapeutically safe and effective amount of:
- a. at least one pharmaceutically active topical anesthetic;
b. at least one pharmaceutically active topical vasodilator; and
c. a pharmaceutically acceptable carrier.
0 Assignments
0 Petitions
Accused Products
Abstract
A composition for topical application comprising a therapeutically effective amount of a topical anesthetic, a safe and effective amount of a pharmaceutically acceptable topical vasodilator and a pharmaceutically acceptable carrier and a method of administering the composition to a mammal are disclosed.
-
Citations
77 Claims
-
1. A local, topical transdermal anesthetic and vasodilator formulation comprising a therapeutically safe and effective amount of:
-
a. at least one pharmaceutically active topical anesthetic;
b. at least one pharmaceutically active topical vasodilator; and
c. a pharmaceutically acceptable carrier. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)
-
-
34. A local, topical transdernal anesthetic and vasodilator formulation, comprising a eutectic mixture of at least one first pharmaceutically active anesthetic, at least one second pharmaceutically active anesthetic in a ratio of from about 15:
- 1 to about 15;
1, and at least one pharmaceutically active vasodilator, in a suitable pharmaceutically acceptable carrier, wherein(a) said at least one first pharmaceutically active anesthetic is selected from the group consisting of benzocaine, lidocaine, bupivacaine, dibucaine, mepivacaine, etidocaine, tetracaine, butanilicaine and trimecaine (b) said at least one second pharmaceutically active anesthetic is selected from the group consisting of prilocaine, tetracaine, butanilicaine and trimecaine, and (c) said at least one first pharmaceutically active anesthetic is different than said at least one second pharmaceutically active anesthetic. - View Dependent Claims (35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70)
- 1 to about 15;
-
71. A method of administering topical anesthetic agents along with a vasodilator comprising the steps of:
-
(a) providing a composition comprising a therapeutically safe and effective amount of at least one topical anesthetic;
a therapeutically safe and effective amount of at least one vasodilator; and
a pharmaceutically acceptable carrier; and
(b) contacting an area of skin of a subject with the composition thereby administering the topical anesthetic and vasodilator, preferably at the site of insertion of an intravenous device. - View Dependent Claims (72, 73, 74, 75, 76, 77)
-
Specification